No black box warning on record for Fluvastatin

As of the latest FDA labeling reviewed, Fluvastatin (FLUVASTATIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Fluvastatin medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Skeletal muscle effects (e.g., myopathy and rhabdomyolysis): Risks increase with advanced age (≥ 65), uncontrolled hypothyroidism, renal impairment, and combination use with cyclosporine,or gemfibrozil. Advise patients to promptly report to their physician unexplained and/or persistent muscle pain, tenderness, or weakness and discontinue fluvastatin if myopathy is diagno

No black box warning on record for Fluvastatin

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Skeletal muscle effects (e.g., myopathy and rhabdomyolysis): Risks increase with advanced age (≥ 65), uncontrolled hypothyroidism, renal impairment, and combination use with cyclosporine,or gemfibrozil. Advise patients to promptly report to their physician unexplained and/or persistent muscle pain, tenderness, or weakness and discontinue fluvastatin if myopathy is diagno

Fluvastatin Black Box Warning

No black box warning on record for Fluvastatin

Other warnings & precautions

Fluvastatin Black Box Warning

No black box warning on record for Fluvastatin

Other warnings & precautions